Glycogen synthase kinase 3, or GSK-3, is a serine/threonine, proline-directed kinase involved in a diverse array of signaling pathways, including glycogen synthesis and cellular adhesion, and has been implicated in Alzheimer’s disease.
Two forms of GSK-3, designated GSK-3 alpha and GSK-3 beta, have been identified and differ in their subcellular localization.
Tau, a microtubule-binding protein which serves to stabilize microtubules in growing axons, is found to be hyper-phosphorylated in paired helical filaments (PHF), the major fibrous component of neurofibrillary lesions associated with Alzheimer’s disease.
Hyperphosphorylation of Tau is thought to be the critical event leading to the assembly of PHF.
Six Tau protein isoforms have been identified, all of which are phosphorylated by GSK-3.
This presents the possibility that miscues in GSK-3 signaling contribute to the onset of Alzheimer’s disease.
Applications:Suitable for use in Immunohistochemistry.
Other applications not tested.
Recommended Dilution:Immunohistochemistry: 1:50-1:200Optimal dilutions to be determined by the researcher.
Storage and Stability:May be stored at 4°C for short-term only.
Aliquot to avoid repeated freezing and thawing.
Store at -20°C.
Aliquots are stable for 12 months.
For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
Size:50ul
Host:rabbit
Source Antibody:human
Grade:Affinity Purified
Purity:Purified by immunoaffinity chromatography.
Form:Supplied as a liquid in PBS, pH 7.2, 15mM sodium azide.
Specificity:Recognizes endogenous levels of human GSK3beta. Species Crossreactivity: mouse and rat
Isotype:IgG
Calc Applications Abbrev:IHC
Calc Crossreactivity:Hu Mo Rt
Immunogen:Synthetic peptide corresponding to residues in human GSK3beta.